Stock listing
NYSE:RFL Rafael Holdings, Inc. Stock
Home listing (NYSE) of Rafael Holdings, Inc.
Follow Rafael Holdings, Inc. into a list and get an email when it puts out news.
Share price · NYSE:RFL
$0.92 USD -0.07 (-6.8%)
Close on Nov 20, 2026
- Day range
- $0.781 – $0.969 USDNov 20, 2026
- Volume
- 156,485 sharesNov 20, 2026
- Market cap
- $47.10M USDAt the close on Nov 20, 2026 · price × 51.21M shares outstanding
- 52-week range
- $0.781 – $3.96 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $233,435 USDMedian day 79,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:RFL · Home | $0.92 USD | -0.067 (-6.8%) | 156,485 | $0.781 | $0.969 | $0.781 | $0.987 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:RFL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.92 | -0.067 | -6.8% | $0.781 | $0.969 | $0.781 | 156,485 | |
| $0.987 | +0.074 | +8.1% | $0.92 | $0.996 | $0.864 | 84,758 | |
| $0.913 | -0.057 | -5.8% | $1.00 | $1.00 | $0.891 | 90,425 | |
| $0.97 | -0.10 | -9.3% | $1.05 | $1.06 | $0.97 | 74,716 | |
| $1.07 | -0.04 | -3.6% | $1.07 | $1.11 | $1.03 | 27,561 | |
| $1.11 | +0.02 | +1.8% | $1.05 | $1.115 | $1.05 | 27,496 | |
| $1.09 | +0.02 | +1.9% | $1.09 | $1.13 | $1.09 | 24,986 | |
| $1.07 | -0.01 | -0.9% | $1.08 | $1.11 | $1.033 | 115,766 | |
| $1.08 | +0.04 | +3.8% | $1.01 | $1.172 | $1.01 | 47,747 | |
| $1.04 | -0.02 | -1.9% | $1.05 | $1.095 | $0.99 | 43,283 | |
| $1.06 | -0.01 | -0.9% | $1.102 | $1.20 | $1.05 | 92,620 | |
| $1.07 | -0.01 | -0.9% | $1.05 | $1.13 | $1.05 | 54,245 | |
| $1.08 | +0.08 | +8.0% | $1.08 | $1.16 | $1.02 | 146,300 | |
| $1.00 | -0.08 | -7.4% | $1.08 | $1.12 | $0.993 | 98,347 | |
| $1.08 | -0.04 | -3.6% | $1.15 | $1.23 | $1.08 | 67,240 | |
| $1.12 | -0.09 | -7.4% | $1.16 | $1.265 | $1.09 | 139,160 | |
| $1.21 | -0.03 | -2.4% | $1.23 | $1.29 | $1.21 | 31,713 | |
| $1.24 | +0.06 | +5.1% | $1.20 | $1.29 | $1.18 | 45,483 | |
| $1.18 | -0.13 | -9.9% | $1.345 | $1.345 | $1.172 | 60,165 | |
| $1.31 | +0.03 | +2.3% | $1.29 | $1.315 | $1.23 | 53,700 | |
| $1.28 | -0.02 | -1.5% | $1.27 | $1.285 | $1.25 | 37,100 | |
| $1.30 | +0.01 | +0.8% | $1.31 | $1.36 | $1.23 | 45,000 | |
| $1.29 | 0.00 | 0.0% | $1.29 | $1.35 | $1.289 | 32,500 | |
| $1.29 | -0.10 | -7.2% | $1.36 | $1.38 | $1.28 | 76,400 | |
| $1.39 | -0.08 | -5.4% | $1.44 | $1.47 | $1.36 | 30,500 | |
| $1.47 | +0.04 | +2.8% | $1.43 | $1.54 | $1.40 | 71,200 | |
| $1.43 | -0.06 | -4.0% | $1.40 | $1.49 | $1.38 | 47,900 | |
| $1.49 | -0.03 | -2.0% | $1.52 | $1.569 | $1.43 | 28,000 | |
| $1.52 | -0.08 | -5.0% | $1.58 | $1.63 | $1.50 | 39,200 | |
| $1.60 | +0.12 | +8.1% | $1.50 | $1.62 | $1.50 | 93,900 | |
| $1.48 | 0.00 | 0.0% | $1.46 | $1.516 | $1.46 | 148,500 | |
| $1.48 | -0.01 | -0.7% | $1.46 | $1.52 | $1.439 | 55,400 | |
| $1.49 | +0.02 | +1.4% | $1.48 | $1.52 | $1.44 | 133,500 | |
| $1.47 | -0.07 | -4.5% | $1.54 | $1.57 | $1.46 | 106,100 | |
| $1.54 | +0.04 | +2.7% | $1.52 | $1.56 | $1.47 | 178,200 | |
| $1.50 | +0.18 | +13.6% | $1.32 | $1.52 | $1.28 | 504,100 | |
| $1.32 | -0.71 | -35.0% | $1.555 | $1.555 | $1.20 | 2,286,800 | |
| $2.03 | +0.01 | +0.5% | $2.04 | $2.143 | $2.00 | 85,300 | |
| $2.02 | +0.08 | +4.1% | $1.91 | $2.19 | $1.91 | 65,800 | |
| $1.94 | +0.03 | +1.6% | $1.93 | $2.04 | $1.93 | 48,900 | |
| $1.91 | -0.11 | -5.4% | $2.00 | $2.04 | $1.84 | 595,900 | |
| $2.02 | +0.02 | +1.0% | $2.01 | $2.06 | $1.97 | 71,300 | |
| $2.00 | 0.00 | 0.0% | $1.97 | $2.10 | $1.97 | 101,068 | |
| $2.00 | -0.05 | -2.4% | $2.035 | $2.087 | $1.96 | 40,235 | |
| $2.05 | -0.01 | -0.5% | $2.05 | $2.10 | $1.95 | 361,500 | |
| $2.06 | 0.00 | 0.0% | $2.15 | $2.15 | $2.01 | 63,800 | |
| $2.06 | -0.08 | -3.7% | $2.14 | $2.183 | $2.05 | 66,400 | |
| $2.14 | -0.04 | -1.8% | $2.14 | $2.22 | $2.09 | 76,700 | |
| $2.18 | -0.10 | -4.4% | $2.23 | $2.32 | $2.121 | 57,400 | |
| $2.28 | -0.08 | -3.4% | $2.36 | $2.43 | $2.24 | 67,500 | |
| $2.36 | +0.07 | +3.1% | $2.26 | $2.585 | $2.245 | 182,400 | |
| $2.29 | -0.14 | -5.8% | $2.42 | $2.49 | $2.28 | 129,800 | |
| $2.43 | -0.13 | -5.1% | $2.68 | $2.763 | $2.43 | 254,600 | |
| $2.56 | +0.09 | +3.6% | $2.49 | $2.74 | $2.49 | 138,500 | |
| $2.47 | -0.04 | -1.6% | $2.51 | $2.64 | $2.391 | 77,300 | |
| $2.51 | +0.07 | +2.9% | $2.43 | $2.65 | $2.43 | 85,900 | |
| $2.44 | -0.13 | -5.1% | $2.55 | $2.55 | $2.34 | 90,500 | |
| $2.57 | +0.01 | +0.4% | $2.56 | $2.65 | $2.37 | 98,300 | |
| $2.56 | +0.19 | +8.0% | $2.39 | $2.819 | $2.39 | 304,600 | |
| $2.37 | +0.08 | +3.5% | $2.31 | $2.52 | $2.30 | 128,500 | |
| $2.29 | +0.05 | +2.2% | $2.27 | $2.35 | $2.20 | 90,700 | |
| $2.24 | +0.05 | +2.3% | $2.22 | $2.319 | $2.18 | 83,107 | |
| $2.19 | +0.03 | +1.4% | $2.16 | $2.20 | $2.03 | 116,642 | |
| $2.16 | +0.31 | +16.8% | $1.85 | $2.20 | $1.85 | 142,100 | |
| $1.85 | +0.04 | +2.2% | $1.82 | $1.94 | $1.77 | 79,300 |
- Ticker
- NYSE:RFL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update
Latest deck · Nov 9, 2026
Investor Presentation (November 2026)
Investor deck · 18 slides
Latest news
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update
Oct 29, 2026
Closed $1.12 (-7.4%) on Oct 29, 2026
Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
Oct 29, 2026
Closed $1.12 (-7.4%) on Oct 29, 2026
Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)
Sep 30, 2026
Closed $1.32 (-35.0%) on Sep 30, 2026
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results
Jun 11, 2026
Closed $2.12 (+19.1%) on Jun 11, 2026
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C
Jun 10, 2026
Closed $1.78 (-7.8%) on Jun 10, 2026
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
Apr 22, 2026
Closed $1.30 (+1.6%) on Apr 22, 2026
Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results
Mar 16, 2026
Closed $1.32 (+0.8%) on Mar 17, 2026
Quarterly Report for Quarter Ending October 31, 2025 (Form 10-Q)
Dec 12, 2025
Closed $1.46 (-2.0%) on Dec 12, 2025
Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results
Dec 11, 2025
Closed $1.46 (-2.0%) on Dec 12, 2025
Rafael Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 9 in the last 12 months · 25 in all · newest Oct 29, 2026 · oldest 2024
- Decks
- 10 decks · latest Nov 9, 2026
Where Rafael Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:RFL · Home listing · This page | NYSE | United States | USD |
| BOATS:RFL | BOATS | United States | USD |
Valuation
EV/sales 28.6× against a median of 5.9×: 4th lowest of 6 Biotechnology companies shown. Statements: Year to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $25.00M USD
- P/E
- Loss
- EV/sales
- 28.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.7×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.92
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Rafael Holdings, Inc. · NYSE:RFL | US$47.10M | US$25.00M | n/a | 28.6× | n/a | 0.7× | n/a | 0.0× | 0.92 |
| SYNTHAVERSE Spolka Akcyjna · GPW:SVE | US$48.66M | US$70.95M | n/a | 5.9× | n/a | 1.7× | −43.1% | 0.8× | n/a |
| Heron Therapeutics, Inc. · NASDAQ:HRTX | US$48.04M | US$156.3M | n/a | 1.1× | n/a | 9.8× | −14.5% | 26.8× | 1.93 |
| Helix BioPharma Corp. · TSX:HBP | US$47.94M | US$50.28M | n/a | n/a | n/a | 4.8× | n/a | 0.3× | 0.36 |
| Oncolytics Biotech Inc. · NASDAQ:ONCY | US$47.66M | US$45.23M | n/a | n/a | n/a | n/a | n/a | n/a | 1.27 |
| THX Pharma · EURONEXT:ALTHX | US$47.23M | US$30.92M | n/a | n/a | n/a | 14.5× | n/a | 0.9× | n/a |
| FluoGuide A/S · OMXSTO:FLUO | US$47.20M | US$43.91M | n/a | 5,539× | n/a | 10.5× | n/a | 0.9× | n/a |
| Bio-fd&c Co. Ltd · KRX:251120 | US$46.46M | US$5.26M | 9.8× | 0.4× | 0.9× | 0.9× | 32.8% | 0.0× | n/a |
| Andros Pharmaceuticals Co., Ltd. · TPEX:6917 | US$46.02M | US$35.89M | n/a | 213× | n/a | 3.1× | −969.3% | 0.0× | n/a |
| Werewolf Therapeutics, Inc. · NASDAQ:HOWL | US$46.01M | US$4.14M | n/a | n/a | n/a | 6.8× | n/a | 0.0× | 1.55 |
| MegaPro Biomedical Co., Ltd. · TPEX:6827 | US$45.96M | US$43.30M | n/a | n/a | n/a | 7.0× | n/a | 0.0× | n/a |
| Median of the others | US$47.21M | US$43.61M | 9.8× | 5.9× | 0.9× | 6.8× | −28.8% | 0.3× | 1.41 |
Team and board
| Director | Role |
|---|---|
| Alan Grayson | Director |
Events
- Next results
- Dec 10, 2026 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q4 2026 | Oct 29, 2026 | −10.7% |
| Q3 2026 | Jun 10, 2026 · After close | +19.1% |
| Q2 2026 | Mar 16, 2026 · After close | +0.8% |
| Q1 2026 | Dec 15, 2025 · After close | 0.0% |
| Q4 2025 | Oct 29, 2025 · Before open | 0.0% |
| Q3 2025 | Jun 11, 2025 | −22.8% |
| Q2 2025 | Mar 11, 2025 · Before open | +4.4% |
| Q1 2025 | Dec 12, 2024 · After close | −2.1% |
| Q4 2024 | Oct 28, 2024 · After close | +1.0% |
| Q2 2024 | Mar 13, 2024 · After close | +3.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Jan 10, 2024 · After close | −2.2% |
| Q4 2023 | Oct 30, 2023 · After close | +3.5% |
| Q3 2023 | Jun 13, 2023 · After close | −2.3% |
| Q2 2023 | Mar 15, 2023 · Before open | −8.7% |
| Q1 2023 | Dec 13, 2022 · Before open | −1.6% |
| Q4 2022 | Oct 31, 2022 · After close | +9.0% |
| Q3 2022 | Jun 14, 2022 · After close | −5.9% |
| Q2 2022 | Mar 17, 2022 · After close | +18.2% |
| Q1 2022 | Dec 15, 2021 · After close | −0.9% |
| Quarter to Jul 31, 2021 | Oct 18, 2021 | +4.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2026) | Investor deck | 18 slides | Nov 9, 2026 |
| Investor Presentation (July 2026) | Investor deck | 24 slides | Jul 8, 2026 |
| Investor Presentation (October 2025) | Investor deck | 23 slides | Oct 10, 2025 |
| Investor Presentation (August 2021) | Investor deck | 31 slides | Aug 10, 2021 |
| Investor Presentation (July 2021) | Investor deck | 29 slides | Jul 14, 2021 |
| Investor Presentation (June 2021) | Investor deck | 30 slides | Jun 21, 2021 |
| LD Micro Investor Conference September 2020 | Conference | 28 slides | Sep 1, 2020 |
| LD Micro Investor Conference 2019 | Conference | 29 slides | Dec 10, 2019 |
| LD Micro 2018 Conference | Conference | 22 slides | Dec 6, 2018 |
| Sidoti and Company Fall 2018 Conference | Conference | 24 slides | Sep 27, 2018 |
Financings
| Raise | Date |
|---|---|
| Rights offering of class B common stock Announced: US$25M · US$1.28 a share Buyers: Howard Jonas (Standby purchaser of any shares of Class B Common Stock not subscribed for in the rights offering, at the same subscription price) Insiders: Executive Chairman Howard Jonas will enter a Standby Purchase Agreement to buy, in a private placement, any shares not subscribed for in the rights offering at the same price. Use of proceeds: Additional capital for the potential launch of Trappsol Cyclo if the TransportNPC Phase 3 48-week interim analysis is positive. | Apr 29, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 874.0K | 917.0K | 637.0K | 279.0K | 410.0K | 802.0K | 4.91M | 4.93M | 4.37M | 5.62M |
| Cost of revenue | 154.0K | 3.50M | 3.17M | |||||||
| Gross profit | 483.0K | -3.09M | -2.37M | |||||||
| Research and development | 24.3M | 12.8M | 4.17M | 6.31M | 8.74M | 4.91M | 2.39M | 1.03M | 995.0K | |
| Selling, general and administrative | 17.0M | 17.0M | 9.12M | 8.82M | 5.52M | 3.73M | ||||
| Operating income | -33.4M | -29.2M | -102.6M | -15.0M | -60.5M | -28.2M | -8.46M | -6.70M | -3.84M | 221.0K |
| Depreciation and amortization | 204.0K | 288.0K | 225.0K | 78.0K | 72.0K | 70.0K | 1.87M | 1.78M | 1.70M | 1.67M |
| EBITDA | -33.2M | -28.9M | -102.4M | -15.0M | -60.4M | -28.1M | -6.60M | -4.92M | -2.14M | 1.89M |
| Interest expense | 333.0K | 658.0K | 248.0K | 6.00K | 12.0K | 0 | ||||
| Income before tax | -28.0M | -33.2M | -67.3M | -8.74M | -140.0M | -23.4M | -6.92M | -4.94M | -3.64M | 204.0K |
| Income tax | -13.0K | -2.55M | -2.68M | -255.0K | 18.0K | 29.0K | -19.0K | 8.44M | 66.0K | |
| Net income | -29.6M | -30.5M | -34.4M | -1.88M | -124.7M | -23.1M | -10.8M | -4.69M | -11.6M | 138.0K |
| Earnings per share, basic | -0.58 | -1.04 | -1.45 | -0.08 | -6.31 | -1.49 | -0.66 | -0.35 | -0.93 | 0.01 |
| Earnings per share, diluted | -0.58 | -1.04 | -1.45 | -0.08 | -6.31 | -1.49 | -0.66 | -0.35 | -0.93 | 0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 22.1M | 52.8M | 2.67M | 21.5M | 26.5M | 7.85M | 6.21M | 12.0M | 15.8M | 11.8M |
| Short-term investments | 63.3M | 57.7M | 36.7M | 24.7M | ||||||
| Receivables | 444.0K | 627.0K | 426.0K | 213.0K | 157.0K | 235.0K | 267.0K | 450.0K | 287.0K | 264.0K |
| Inventory | 377.0K | 281.0K | ||||||||
| Current assets | 25.8M | 56.7M | 72.5M | 82.9M | 108.3M | 14.8M | 9.83M | 13.3M | 44.5M | 12.2M |
| Property, plant and equipment | 1.50M | 1.60M | 2.12M | 1.70M | 1.77M | 1.84M | 44.4M | 48.7M | 50.1M | 51.2M |
| Goodwill | 19.9M | 19.9M | 3.05M | |||||||
| Total assets | 83.1M | 114.1M | 96.8M | 98.8M | 118.3M | 154.1M | 136.3M | 142.1M | 116.9M | 86.2M |
| Accounts payable | 7.01M | 6.89M | 2.56M | 333.0K | 564.0K | 1.16M | 921.0K | 795.0K | 367.0K | 115.0K |
| Current liabilities | 11.0M | 11.6M | 7.51M | 2.15M | 21.0M | 17.3M | 5.73M | 1.43M | 891.0K | 363.0K |
| Total liabilities | 11.1M | 15.7M | 10.6M | 2.20M | 21.1M | 17.4M | 5.82M | 17.4M | 1.35M | 24.1M |
| Shareholders' equity | 66.3M | 94.4M | 82.2M | 100.3M | 100.5M | 122.3M | 116.8M | 111.0M | 106.7M | 52.7M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -30.0M | -18.9M | -7.80M | -10.9M | -26.1M | -15.6M | -4.67M | -3.13M | -1.81M | -1.62M |
| Capital spending | -3.00K | -4.00K | -143.0K | -2.00K | -206.0K | -534.0K | -399.0K | -710.0K | -1.82M | |
| Free cash flow | -30.0M | -18.9M | -7.95M | -26.1M | -15.8M | -5.20M | -3.53M | -2.52M | -3.44M | |
| Cash from investing | -676.0K | 44.0M | -10.8M | 21.2M | -63.8M | -8.17M | -1.03M | -31.2M | 4.11M | -11.2M |
| Cash from financing | -116.0K | 24.8M | -179.0K | -15.2M | 103.9M | 30.3M | -96.0K | 30.9M | 1.75M | 22.3M |
| Change in cash | -30.7M | 50.1M | -18.8M | -5.04M | 13.7M | 6.65M | -5.82M | -3.78M | 4.05M | 9.42M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| DEF 14A · Proxy statement | Nov 16, 2026 | Meeting notice | SEC |
| 8-K · Current report | Nov 9, 2026 | Current report | SEC |
| 10-K · Annual report | Oct 29, 2026 | Annual report | SEC |
| 8-K · Current report | Oct 29, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 27, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 30, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 31, 2026 | Insider trade | SEC |
| 8-K · Current report | Jul 8, 2026 | Current report | SEC |
| 4 · Change in ownership | Jun 23, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jun 16, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 11, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jun 11, 2026 | Results | SEC |
| 8-K · Current report | Jun 10, 2026 | Current report | SEC |
| 8-K · Current report | Apr 22, 2026 | Current report | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Mar 16, 2026 | Quarterly report | SEC |
| 8-K · Current report | Mar 16, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 29, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 29, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jan 27, 2026 | Offer document | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 15, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 12, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Dec 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 16, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Dec 11, 2025 | Quarterly report | SEC |
| 8-K · Current report | Dec 11, 2025 | Results | SEC |
| 25-NSE | Dec 11, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 2, 2025 | Current report | SEC |
| DEF 14A · Proxy statement | Nov 18, 2025 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Oct 31, 2025 | Insider trade | SEC |
| 10-K · Annual report | Oct 29, 2025 | Annual report | SEC |
| 8-K · Current report | Oct 29, 2025 | Results | SEC |
| 8-K · Current report | Oct 28, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Oct 28, 2025 | Insider trade | SEC |
| 8-K · Current report | Oct 10, 2025 | Current report | SEC |
| 4 · Change in ownership | Sep 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 11, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 7, 2025 | Management or board change | SEC |
| 3 · Initial statement of ownership | Jul 22, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 18, 2025 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Jun 26, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 18, 2025 | Current report | SEC |
| 4 · Change in ownership | Jun 17, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 11, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jun 11, 2025 | Results | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 9, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 9, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 9, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 4, 2025 | Financing | SEC |
| 4 · Change in ownership | May 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 8-K/A · Current report, amended | May 20, 2025 | Current report | SEC |
| 8-K · Current report | May 6, 2025 | Material contract | SEC |
| 424B3 · Prospectus | May 6, 2025 | Offer document | SEC |
| 8-K/A · Current report, amended | May 5, 2025 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Apr 30, 2025 | Other filings | SEC |
| 8-K · Current report | Apr 29, 2025 | Current report | SEC |
| CORRESP · Letter to the SEC | Apr 28, 2025 | Other filings | SEC |
| S-3/A · Registration statement, amended | Apr 28, 2025 | Offer document | SEC |
| 8-K/A · Current report, amended | Apr 28, 2025 | Current report | SEC |
| 8-K · Current report | Apr 24, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Apr 24, 2025 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Apr 21, 2025 | Other filings | SEC |
| S-3 · Registration statement | Apr 18, 2025 | Offer document | SEC |
| 3 · Initial statement of ownership | Apr 2, 2025 | Insider trade | SEC |
| CERT · Exchange's certificate of listing | Mar 26, 2025 | Other filings | SEC |
| 8-K · Current report | Mar 26, 2025 | Acquisition or disposal | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 24, 2025 | Meeting outcome | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Mar 17, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Mar 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Mar 13, 2025 | Results | SEC |
| UPLOAD · Letter from the SEC | Feb 14, 2025 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Feb 14, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Feb 13, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 13, 2025 | Other filings | SEC |
| S-4/A · Registration statement, amended | Feb 13, 2025 | Offer document | SEC |
| S-4/A · Registration statement, amended | Feb 11, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 11, 2025 | Other filings | SEC |
| 8-K · Current report | Feb 10, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jan 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 15, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 13, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Jan 13, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Jan 10, 2025 | Other filings | SEC |
| S-4/A · Registration statement, amended | Jan 10, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jan 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2025 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Jan 8, 2025 | Other filings | SEC |
| 10-K/A · Annual report, amended | Jan 8, 2025 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Jan 3, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 3, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 23, 2024 | Current report | SEC |
| 4 · Change in ownership | Dec 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 23, 2024 | Insider trade | SEC |
| S-4/A · Registration statement, amended | Dec 20, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 19, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 19, 2024 | Other filings | SEC |
| 10-K/A · Annual report, amended | Dec 19, 2024 | Annual report | SEC |
| UPLOAD · Letter from the SEC | Dec 11, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Dec 11, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Dec 11, 2024 | Quarterly report | SEC |
| 8-K · Current report | Dec 11, 2024 | Results | SEC |
| S-4/A · Registration statement, amended | Nov 22, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 21, 2024 | Other filings | SEC |
| DEF 14A · Proxy statement | Nov 19, 2024 | Meeting notice | SEC |
| 10-K · Annual report | Nov 6, 2024 | Annual report | SEC |
| 8-K · Current report | Nov 6, 2024 | Results | SEC |
| UPLOAD · Letter from the SEC | Nov 5, 2024 | Other filings | SEC |
| NT 10-K · Late filing notice | Oct 30, 2024 | Explanation request | SEC |
| 4 · Change in ownership | Oct 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2024 | Insider trade | SEC |
| S-4 · Registration statement | Oct 9, 2024 | Offer document | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 30, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 24, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 24, 2024 | Insider trade | SEC |
| 425 | Aug 22, 2024 | Other filings | SEC |
| 8-K · Current report | Aug 22, 2024 | Material contract | SEC |
| 3 · Initial statement of ownership | Aug 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 8, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jul 26, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jun 18, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 17, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jun 14, 2024 | Results | SEC |
| 8-K/A · Current report, amended | May 23, 2024 | Current report | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Mar 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Mar 13, 2024 | Results | SEC |
| 8-K · Current report | Mar 13, 2024 | Acquisition or disposal | SEC |
| 4 · Change in ownership | Feb 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 18, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2024 | Meeting outcome | SEC |
| 3 · Initial statement of ownership | Jan 12, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 12, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Dec 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Dec 14, 2023 | Results | SEC |
| DEFR14A | Nov 20, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Nov 20, 2023 | Meeting notice | SEC |
| 10-K · Annual report | Oct 30, 2023 | Annual report | SEC |
| 8-K · Current report | Oct 30, 2023 | Results | SEC |
| 8-K · Current report | Oct 26, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Oct 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2023 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Oct 24, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 23, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 30, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 29, 2023 | Offer document | SEC |
| 8-K · Current report | Aug 9, 2023 | Management or board change | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 7, 2023 | Big-stake notice | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 3, 2023 | Big-stake notice | SEC |
| 8-K/A · Current report, amended | Aug 2, 2023 | Current report | SEC |
| 4 · Change in ownership | Aug 2, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 2, 2023 | Current report | SEC |
| 4 · Change in ownership | Aug 1, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Jun 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 13, 2023 | Results | SEC |
| 8-K · Current report | Jun 5, 2023 | Current report | SEC |
| SC 13D · Big-stake notice | May 11, 2023 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | May 8, 2023 | Insider trade | SEC |
| 8-K · Current report | Apr 4, 2023 | Current report | SEC |
| 4 · Change in ownership | Mar 23, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Mar 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Mar 14, 2023 | Results | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 28, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 2, 2023 | Management or board change | SEC |
| 3 · Initial statement of ownership | Jan 30, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 26, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Jan 5, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 23, 2022 | Insider trade | SEC |
This page holds 200 of 411 filings. Open Filings
Cap table
Built by 6ix from Rafael Holdings, Inc.’s releases · as of Apr 29, 2025
- Common shares
- 51,212,833
- Fully diluted
- 51,212,833
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 51,212,833 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 51,212,833 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Howard S. Jonas Other companies: IDW Media Holdings, Inc. (Chairman of the Board of Directors · Since at least Jul 1, 2021); Zedge, Inc. (Director · Since at least May 9, 2016); Genie Energy Ltd. (Chairman of the Board · Since at least Oct 25, 2011); IDT Corporation (Chairman of the Board · Since at least Dec 20, 2006) | Exec Chairman, CEO & President, Director · Since at least Jan 2, 2018 |
| Mark Anthony McCamish Other companies: Avadel Pharmaceuticals PLC (Director · Since at least Dec 5, 2019); Forty Seven Inc (President and CEO, Director · Jun 27, 2018 – Apr 7, 2020 · Past); Facet Biotech Corp (Sr. VP & Chief Medical Officer · Dec 9, 2008 – Apr 2, 2009 · Past); PDL BioPharma Inc (SVP & CMO · Feb 21, 2007 – Dec 18, 2008 · Past) | Director · Jun 14, 2021 – Jan 5, 2024 · Past |
| N. Scott Fine Other companies: Anghami Inc. (Director · Since at least Jun 29, 2026); Kenon Holdings Ltd. (Board Member · Since at least Mar 16, 2026); Cyclo Therapeutics Inc (Chief Executive Officer, Director · Apr 24, 2020 – Jun 3, 2024 · Past); Forward Industries, Inc. (Director · Jan 5, 2015 – Jun 10, 2017 · Past) | Director · Since at least Jul 14, 2025 |
| Patrick Fabbio Other companies: BeyondSpring, Inc. (Director · Since at least Dec 31, 2024); Protara Therapeutics, Inc. (Chief Financial Officer · Since at least Jan 30, 2023); Progenics Pharmaceuticals Inc (CFO · Nov 16, 2015 – Mar 2, 2020 · Past) | CFO & President · Sep 13, 2021 – Dec 21, 2022 · Past |
| William Conkling Other companies: IDT Corporation (Director · Since at least Jun 9, 2026); Protara Therapeutics, Inc. (Chief Commercial Officer · Since at least Jun 2, 2025); Cyclo Therapeutics Inc (Director · May 2, 2023 – Feb 27, 2025 · Past) | Chief Executive Officer · Mar 15, 2021 – Mar 25, 2025 · Past |
| Ameet Mallik Other companies: ADC Therapeutics SA (Chief Executive Officer · Since at least Jan 2, 2024); Atara Biotherapeutics, Inc. (Director · Since at least Aug 9, 2021) | Director · May 1, 2021 – Feb 1, 2022 · Past |
| David Polinsky Other companies: Ernexa Therapeutics Inc. (Director · Since at least Aug 4, 2026); Innovative Food Holdings, Inc. (Director · Jul 24, 2019 – Mar 23, 2020 · Past) | Chief Financial Officer · Since at least Jan 2, 2018 |
| Joyce J. Mason Other companies: Genie Energy Ltd. (Director and Corporate Secretary · Since at least May 12, 2021); IDT Corporation (EVP and General Counsel · Since at least Feb 1, 2005) | Director · Jan 2, 2018 – Jan 2, 2018 · Past |
| Stephen M Greenberg Other companies: Zedge, Inc. (Director · May 23, 2016 – Jan 5, 2018 · Past); Net2Phone Inc (Director · Dec 29, 2005 – Dec 29, 2005 · Past) | Director · Mar 8, 2018 – Jan 6, 2025 · Past |
| Ashok D Marin Other companies: LipoScience Inc (VP, General Counsel · Jan 24, 2013 – Jan 24, 2013 · Past) | Chief Legal Officer · Sep 20, 2021 – Sep 24, 2021 · Past |
All 22 people
| Person | Seat |
|---|---|
| Joshua M Fine Other companies: Cyclo Therapeutics Inc (Chief Financial Officer · Nov 23, 2020 – Jun 3, 2024 · Past) | Chief Operating Officer · Since at least Aug 4, 2025 |
| Markus Sieger Other companies: Cyclo Therapeutics Inc (Director · Apr 24, 2020 – Feb 27, 2025 · Past) | Director · Since at least Mar 25, 2025 |
| Menachem Ash Other companies: IDT Corporation (EVP Strategy & Legal Affairs · Since at least Oct 23, 2012) | President · Jan 2, 2018 – Jan 5, 2021 · Past |
| Shannon Thyme Klinger Other companies: Moderna, Inc. (Chief Legal Officer · Since at least Jun 1, 2021) | Director · Jun 14, 2021 – Jan 5, 2022 · Past |
| Alan Grayson | Director · Since at least Oct 23, 2025 |
| Boris C Pasche | Director · Mar 8, 2018 – Jan 5, 2023 · Past |
| John Goldberg | CHIEF MEDICAL OFFICER · Nov 20, 2023 – Jan 13, 2025 · Past |
| Mark N Stein | Director · Since at least Aug 5, 2024 |
| Mary Margaret Huizinga | Chief Devel. & Medical Officer · Oct 18, 2021 – Oct 18, 2021 · Past |
| Michael J Weiss | Director · Since at least Mar 8, 2018 |
| Rachel Jonas | Director · Jan 13, 2021 – Jan 13, 2021 · Past |
| Susan Y Bernstein | Director · Jan 10, 2024 – Jan 10, 2024 · Past |
Log in to ask 6ix AI your own questions about Rafael Holdings, Inc.